We found that disruption of the GRK/β-arrestin-2 pathway of desensitization did not alter sensitivity and/or tolerance to the anti-allodynic effects of either 6 or 10 mg/kg of ∆9-THC in a model of cisplatin-evoked neuropathy. Here, GZMK is linked to neuropathy.